Toxoplasma gondii effectors are master regulators of the inflammatory response

Trends in Parasitology

Volumn 27, Issue 11, 2011, Pages 487-495

  Melo, Mariane B ^a   Jensen, Kirk D C ^a   Saeij, Jeroen P J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULE PROTEIN 15; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; NUCLEOSIDE TRIPHOSPHATASE; PARASITE EFFECTOR PROTEIN; PEPTIDES AND PROTEINS; PROTEIN; PROTEIN KINASE; REACTIVE NITROGEN SPECIES; RHOPTRY PROTEIN KINASE 16; RHOPTRY PROTEIN KINASE 18; RHOPTRY PROTEIN KINASE 38; RHOPTRY PROTEIN KINASE 5; STAT1 PROTEIN; TOLL LIKE RECEPTOR; TRYPTOPHAN; UNCLASSIFIED DRUG;

AUTOPHAGY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL INVASION; CYTOKINE PRODUCTION; DNA POLYMORPHISM; ENZYME ACTIVITY; GENE EXPRESSION; GENE MAPPING; IMMUNE RESPONSE; INFLAMMATION; MOUTH INFECTION; NONHUMAN; PARASITE LOAD; PARASITE TRANSMISSION; PARASITE VIRULENCE; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW; TOXOPLASMA GONDII;

ANIMALS; HOST-PARASITE INTERACTIONS; HUMANS; PROTOZOAN PROTEINS; TOXOPLASMA; TOXOPLASMOSIS; VIRULENCE; VIRULENCE FACTORS;

TOXOPLASMA; TOXOPLASMA GONDII;

EID: 80054792189     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2011.08.001     Document Type: Review

References (99)

1. Dubremetz J.F. Host cell invasion by Toxoplasma gondii. Trends Microbiol. 1998, 6:27-30.
2. Hill D., Dubey J.P. Toxoplasma gondii: transmission, diagnosis and prevention. Clin. Microbiol. Infect. 2002, 8:634-640.
3. Morisaki J.H., et al. Invasion of Toxoplasma gondii occurs by active penetration of the host cell. J. Cell Sci. 1995, 108(Pt 6):2457-2464.
4. Plattner F., Soldati-Favre D. Hijacking of host cellular functions by the Apicomplexa. Annu. Rev. Microbiol. 2008, 62:471-487.
5. Dubey J.P., et al. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin. Microbiol. Rev. 1998, 11:267-299.
6. Blader I.J., Saeij J.P. Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence. APMIS 2009, 117:458-476.
7. Peixoto L., et al. Integrative Genomic Approaches Highlight a Family of Parasite-Specific Kinases that Regulate Host Responses. Cell Host Microbe 2010, 8:208-218.
8. Gazzinelli R.T., et al. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 1994, 153:2533-2543.
9. Pifer R., Yarovinsky F. Innate responses to Toxoplasma gondii in mice and humans. Trends Parasitol. 2011, 27:388-393.
10. Gazzinelli R.T., et al. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:6115-6119.
11. Zhao Y.O., et al. Disruption of the Toxoplasma gondii parasitophorous vacuole by IFNgamma-inducible immunity-related GTPases (IRG proteins) triggers necrotic cell death. PLoS Pathog. 2009, 5:e1000288.
12. Zhao Y., et al. Virulent Toxoplasma gondii evade immunity-related GTPase-mediated parasite vacuole disruption within primed macrophages. J. Immunol. 2009, 182:3775-3781.
13. Scharton-Kersten T.M., et al. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 1997, 185:1261-1273.
14. Pfefferkorn E.R. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. U.S.A. 1984, 81:908-912.
15. Andrade R.M., et al. CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes. J. Clin. Invest. 2006, 116:2366-2377.
16. Ling Y.M., et al. Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages. J. Exp. Med. 2006, 203:2063-2071.
17. Witola W.H., et al. NALP1 influences susceptibility to human congenital toxoplasmosis, pro-inflammatory cytokine response and fate of T. gondii-Infected monocytic cells. Infect. Immun. 2010.
18. Lees M.P, et al. P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages. J. Immunol. 2010, 184:7040-7046.
19. Gazzinelli R.T., et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 1996, 157:798-805.
20. Suzuki Y., et al. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J. Immunol. 2000, 164:5375-5382.
21. Vossenkämper A., et al. Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite control. Eur. J. Immunol. 2004, 34:3197-3207.
22. Sibley L.D., Ajioka J.W. Population structure of Toxoplasma gondii: clonal expansion driven by infrequent recombination and selective sweeps. Annu. Rev. Microbiol. 2008, 62:329-351.
23. Sibley L.D., Boothroyd J.C. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 1992, 359:82-85.
24. Taylor S., et al. A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 2006, 314:1776-1780.
25. Saeij J.P.J., et al. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 2006, 314:1780-1783.
26. Behnke M.S., et al. Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:9631-9636.
27. El Hajj H., et al. ROP18 is a rhoptry kinase controlling the intracellular proliferation of Toxoplasma gondii. PLoS Pathog. 2007, 3:e14.
28. Fentress S.J., et al. Phosphorylation of Immunity-Related GTPases by a Toxoplasma gondii-Secreted Kinase Promotes Macrophage Survival and Virulence. Cell Host Microbe 2010, 8:484-495.
29. Steinfeldt T., et al. Phosphorylation of mouse immunity-related GTPase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii. PLoS Biol. 2010, 8:e1000576.
30. Pawlowski N., et al. The activation mechanism of Irga6, an interferon-inducible GTPase contributing to mouse resistance against Toxoplasma gondii. BMC Biol. 2011, 9:7.
31. Hunn J.P., et al. The immunity-related GTPases in mammals: a fast-evolving cell-autonomous resistance system against intracellular pathogens. Mamm. Genome 2010, 22:43-54.
32. Singh S.B., et al. Human IRGM regulates autophagy and cell-autonomous immunity functions through mitochondria. Nat. Cell Biol. 2010, 12:1154-1165.
33. Singh S.B., et al. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 2006, 313:1438-1441.
34. Yamamoto M., et al. ATF6{beta} is a host cellular target of the Toxoplasma gondii virulence factor ROP18. J. Exp. Med. 2011, 208:1533-1546.
35. Goldszmid R.S., et al. Host ER-parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in Toxoplasma gondii-infected dendritic cells. J. Exp. Med. 2009, (Suppl. 206):399-410.
36. Reese M.L., Boothroyd J.C. A helical membrane-binding domain targets the Toxoplasma ROP2 family to the parasitophorous vacuole. Traffic 2009, 10:1458-1470.
37. Reese M.L., et al. A polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:9625-9630. 10.1073/pnas.1015980108.
38. El Hajj H., et al. The ROP2 family of Toxoplasma gondii rhoptry proteins: proteomic and genomic characterization and molecular modeling. Proteomics 2006, 6:5773-5784.
39. Reese M.L., Boothroyd J.C. A conserved noncanonical motif in the pseudoactive site of the ROP5 pseudokinase domain mediates its effect on Toxoplasma virulence. J. Biol. Chem. 2011, 286:29366-29375. 10.1074/jbc.M111.253435.
40. El Hajj H., et al. Inverted topology of the Toxoplasma gondii ROP5 rhoptry protein provides new insights into the association of the ROP2 protein family with the parasitophorous vacuole membrane. Cell. Microbiol. 2007, 9:54-64.
41. Saeij J.P.J., et al. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 2007, 445:324-327.
42. Rosowski E.E., et al. Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. J. Exp. Med. 2011, 208:195-212.
43. Jensen K.D., et al. Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammation. Cell Host Microbe 2011, 9:472-483.
44. Ong Y.-C., et al. Toxoplasma rhoptry protein 16 (ROP16) subverts host function by direct tyrosine phosphorylation of STAT6. J. Biol. Chem. 2010, 285:28731-28740.
45. Yamamoto M., et al. A single polymorphic amino acid on Toxoplasma gondii kinase ROP16 determines the direct and strain-specific activation of Stat3. J. Exp. Med. 2009, 206:2747-2760.
46. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003, 3:133-146.
47. Leng J., et al. Dysregulation of macrophage signal transduction by Toxoplasma gondii: past progress and recent advances. Parasite Immunol. 2009, 31:717-728.
48. Robben P.M., et al. Production of IL-12 by macrophages infected with Toxoplasma gondii depends on the parasite genotype. J. Immunol. 2004, 172:3686-3694.
49. Asai T., et al. Detection of nucleoside triphosphate hydrolase as a circulating antigen in sera of mice infected with Toxoplasma gondii. Infect. Immun. 1987, 55:1332-1335.
50. Asai T., et al. High correlation in antibody titers between the Sabin-Feldman dye test and an enzyme-linked immunosorbent assay detecting immunoglobulin G antibodies to the nucleoside triphosphate hydrolase of Toxoplasma gondii. J. Clin. Microbiol. 1992, 30:1291-1293.
51. Asai T., et al. Biochemical and molecular characterization of nucleoside triphosphate hydrolase isozymes from the parasitic protozoan Toxoplasma gondii. J. Biol. Chem. 1995, 270:11391-11397.
52. Stutz A., et al. Inflammasomes: too big to miss. J. Clin. Invest. 2009, 119:3502-3511.
53. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
54. Corrêa G., et al. Activation of the P2X(7) receptor triggers the elimination of Toxoplasma gondii tachyzoites from infected macrophages. Microbes Infect. 2010, 12:497-504.
55. Miao E.A., et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat. Immunol. 2010, 11:1136-1142.
56. Mordue D.G., et al. A patatin-like protein protects Toxoplasma gondii from degradation in activated macrophages. Mol. Microbiol. 2007, 63:482-496.
57. Pollard A.M., et al. A transmembrane domain-containing surface protein from Toxoplasma gondii augments replication in activated immune cells and establishment of a chronic infection. Infect. Immun. 2009, 77:3731-3739.
58. Fox B.A, et al. Efficient gene replacements in Toxoplasma gondii strains deficient for nonhomologous end joining. Eukaryot. Cell 2009, 8:520-529.
59. Yarovinsky F., et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005, 308:1626-1629.
60. Zimmermann S., et al. Induction of suppressor of cytokine signaling-1 by Toxoplasma gondii contributes to immune evasion in macrophages by blocking IFN-gamma signaling. J. Immunol. 2006, 176:1840-1847.
61. Boothroyd J.C. Expansion of host range as a driving force in the evolution of Toxoplasma. Mem. Inst. Oswaldo Cruz 2009, 104:179-184.
62. Mills C.D., et al. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 2000, 164:6166-6173.
63. Dunay I.R., et al. Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity 2008, 29:306-317.
64. Dunay I.R., et al. Inflammatory monocytes but not neutrophils are necessary to control infection with Toxoplasma gondii in mice. Infect. Immun. 2010, 78:1564-1570.
65. Sergent V., et al. Innate refractoriness of the Lewis rat to toxoplasmosis is a dominant trait that is intrinsic to bone marrow-derived cells. Infect. Immun. 2005, 73:6990-6997.
66. Cavaillès P., et al. The rat Toxo1 locus directs toxoplasmosis outcome and controls parasite proliferation and spreading by macrophage-dependent mechanisms. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:744-749.
67. Jamieson S.E., et al. Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and toxoplasmosis. Genes Immun. 2010, 11:374-383.
68. Hitziger N., et al. Dissemination of Toxoplasma gondii to immunoprivileged organs and role of Toll/interleukin-1 receptor signalling for host resistance assessed by in vivo bioluminescence imaging. Cell Microbiol. 2005, 7:837-848.
69. Liesenfeld O., et al. Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J. Exp. Med. 1996, 184:597-607.
70. Kong J.T., et al. Serotyping of Toxoplasma gondii infections in humans using synthetic peptides. J. Infect. Dis. 2003, 187:1484-1495.
71. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
72. Gazzinelli R.T., Denkers E.Y. Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat. Rev. Immunol. 2006, 6:895-906.
73. Sukhumavasi W., et al. TLR adaptor MyD88 is essential for pathogen control during oral Toxoplasma gondii infection but not adaptive immunity induced by a vaccine strain of the parasite. J. Immunol. 2008, 181:3464-3473.
74. Scanga C.A., et al. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 2002, 168:5997-6001.
75. Liu C.-H., et al. Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice. J. Immunol. 2006, 177:31-35.
76. LaRosa D.F., et al. T cell expression of MyD88 is required for resistance to Toxoplasma gondii. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3855-3860.
77. Melo M.B., et al. UNC93B1 mediates host resistance to infection with Toxoplasma gondii. PLoS Pathog. 2010, 6.
78. Sims J.E., Smith D.E. The IL-1 family: regulators of immunity. Nat. Rev. Immunol. 2010, 10:89-102.
79. Adachi O., et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998, 9:143-150.
80. Hunter C.A., et al. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens. J. Immunol. 1995, 155:4347-4354.
81. Cai G., et al. Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii. Infect. Immun. 2000, 68:6932-6938.
82. Jones L.A, et al. IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii. Eur. J. Immunol. 2010, 40:426-436.
83. Dardé M.-L. Genetic analysis of the diversity in Toxoplasma gondii. Ann. Ist. Super. Sanita 2004, 40:57-63.
84. Khan A., et al. Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg. Infect. Dis. 2006, 12:942-949.
85. Pena H.F.J., et al. Population structure and mouse-virulence of Toxoplasma gondii in Brazil. Int. J. Parasitol. 2008, 38:561-569.
86. Miller M.A., et al. An unusual genotype of Toxoplasma gondii is common in California sea otters (Enhydra lutris nereis) and is a cause of mortality. Int. J. Parasitol. 2004, 34:275-284.
87. Khan A., et al. Recent transcontinental sweep of Toxoplasma gondii driven by a single monomorphic chromosome. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:14872-14877.
88. Boothroyd J.C., Grigg M.E. Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease?. Curr. Opin. Microbiol. 2002, 5:438-442.
89. Holland G.N. Reconsidering the pathogenesis of ocular toxoplasmosis. Am. J. Ophthalmol. 1999, 128:502-505.
90. Roberts F., McLeod R. Pathogenesis of toxoplasmic retinochoroiditis. Parasitol. Today 1999, 15:51-57.
91. Grigg M.E., et al. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J. Infect. Dis. 2001, 184:633-639.
92. Plattner F., et al. Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response. Cell Host Microbe 2008, 3:77-87.
93. Debierre-Grockiego F., et al. Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii. J. Immunol. 2007, 179:1129-1137.
94. Kim L., et al. Toxoplasma gondii genotype determines MyD88-dependent signaling in infected macrophages. J. Immunol. 2006, 177:2584-2591.
95. Aliberti J., et al. CCR5 provides a signal for microbial induced production of IL-12 by CD8 alpha+ dendritic cells. Nat. Immunol. 2000, 1:83-87.
96. Tait E.D., et al. Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells. J. Immunol. 2010, 185:1502-1512.
97. Denkers E.Y., Gazzinelli R.T. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 1998, 11:569-588.
98. Muñoz M., et al. Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J. Exp. Med. 2009, 206:3047-3059.
99. Kelly M.N., et al. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect. Immun. 2005, 73:617-621.